These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 570074)

  • 1. Very pure porcine insulin in clinical practice.
    Wright AD; Walsh CH; Fitzgerald MG; Malins JM
    Br Med J; 1979 Jan; 1(6155):25-7. PubMed ID: 570074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipohypertrophy and lipoatrophy complicating treatment with highly purified bovine and porcine insulins.
    McNally PG; Jowett NI; Kurinczuk JJ; Peck RW; Hearnshaw JR
    Postgrad Med J; 1988 Nov; 64(757):850-3. PubMed ID: 3076667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical lipodystrophic changes due to conventional bovine and highly purified porcine/bovine insulins.
    Campbell IW; Duncan C; Anani AR
    Postgrad Med J; 1984 Jun; 60(704):439-41. PubMed ID: 6379631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of insulin lipoatrophy. A case report.
    Asherov J; Mimouni M; Laron Z
    Diabete Metab; 1979 Mar; 5(1):1-3. PubMed ID: 571820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change of insulin dosage, circulating free and bound insulin and insulin antibodies on transferring diabetics from conventional to highly purified porcine insulin.
    Asplin CM; Hartog M; Goldie DJ
    Diabetologia; 1978 Feb; 14(2):99-105. PubMed ID: 631462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin-related complications of insulin therapy: epidemiology and emerging management strategies.
    Richardson T; Kerr D
    Am J Clin Dermatol; 2003; 4(10):661-7. PubMed ID: 14507228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The place of "monocomponent" insulins in diabetes mellitus therapy].
    Teuscher A
    Schweiz Med Wochenschr; 1975 Apr; 105(16):485-94. PubMed ID: 1215860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of new insulins on insulin and C-peptide antibodies, insulin dose, and diabetic control.
    Peacock I; Tattersall RB; Taylor A; Douglas CA; Reeves WG
    Lancet; 1983 Jan; 1(8317):149-52. PubMed ID: 6130198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membranous lipodystrophy associated with insulin lipoatrophy.
    Kim KT; Ahn SK; Choi EH; Lee SH
    Int J Dermatol; 1997 Apr; 36(4):299-301. PubMed ID: 9169335
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin-induced lipodystrophy in diabetic patients resolved by treatment with human insulin.
    Valenta LJ; Elias AN
    Ann Intern Med; 1985 Jun; 102(6):790-1. PubMed ID: 3888023
    [No Abstract]   [Full Text] [Related]  

  • 11. The immunogenicity of insulin preparations.
    Chance RE; Root MA; Galloway JA
    Acta Endocrinol Suppl (Copenh); 1976; 205():185-98. PubMed ID: 793278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contribution to the study of insulin lipodystrophy. Attempt at treatment with hog insulin].
    Gleize J; François R; Plauchu M
    Diabete; 1968; 16(4):281-8. PubMed ID: 5753391
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized prospective trial of pure porcine and conventional bovine/porcine insulin.
    Asplin C; Raghu P; Clemons P; Lyen K; Tatpati O; McKnight B; Baker L; Guthrie R; Sperling M; Palmer J
    Diabetes Care; 1987; 10(3):337-42. PubMed ID: 2954800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological potency of porcine, bovine and human insulins in the rabbit bioassay system.
    Pingel M; Vølund A; Sørensen E; Collins JE; Dieter CT
    Diabetologia; 1985 Nov; 28(11):862-9. PubMed ID: 3910496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical comparison of purified bovine and purified porcine insulins.
    Olczak SA; Greenwood RH
    Postgrad Med J; 1985 Jan; 61(711):15-8. PubMed ID: 3887349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-induced lipoatrophy: evidence for an immune pathogenesis.
    Reeves WG; Allen BR; Tattersall RB
    Br Med J; 1980 Jun; 280(6230):1500-3. PubMed ID: 6992934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of administration of highly purified insulin preparations on regression of post-insulin lipoatrophy in diabetics].
    Rogala H; Lawecki J; Ludwiczak H; Symonides-Lawecka A
    Pol Arch Med Wewn; 1978 Mar; 59(3):331-9. PubMed ID: 673882
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of insulin antibodies on insulin dose and diabetic control.
    Walford S; Allison SP; Reeves WG
    Diabetologia; 1982 Feb; 22(2):106-10. PubMed ID: 7037511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe lipoatrophy with insulin in type 1 diabetes.
    Ma X; Lv H; Li Q; Shen J
    J Dermatol; 2012 Jun; 39(6):578-9. PubMed ID: 22097884
    [No Abstract]   [Full Text] [Related]  

  • 20. [Insulin lipoatrophy and its elimination through the use of monocomponent insulin].
    Maaz E
    Z Gesamte Inn Med; 1976 Nov; 31(22):941-5. PubMed ID: 1035452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.